{"organizations": [], "uuid": "60a5d117b3109cd3a74d8a112d3a9b589918c092", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-heidelberg-pharma-and-advanced-pro/brief-heidelberg-pharma-and-advanced-proteome-therapeutics-progress-collaborative-program-idUSFWN1P30VV", "country": "US", "domain_rank": 408, "title": "BRIEF-Heidelberg Pharma And Advanced Proteome Therapeutics Progress Collaborative Program", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.489, "site_type": "news", "published": "2018-01-09T01:06:00.000+02:00", "replies_count": 0, "uuid": "60a5d117b3109cd3a74d8a112d3a9b589918c092"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-heidelberg-pharma-and-advanced-pro/brief-heidelberg-pharma-and-advanced-proteome-therapeutics-progress-collaborative-program-idUSFWN1P30VV", "ord_in_thread": 0, "title": "BRIEF-Heidelberg Pharma And Advanced Proteome Therapeutics Progress Collaborative Program", "locations": [], "entities": {"persons": [], "locations": [{"name": "heidelberg", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "pharma ag", "sentiment": "negative"}, {"name": "brief-heidelberg pharma and advanced proteome therapeutics progress collaborative program", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - HEIDELBERG PHARMA AG:\n* DGAP-NEWS: HEIDELBERG PHARMA AG AND ADVANCED PROTEOME THERAPEUTICS PROGRESS COLLABORATIVE PROGRAM Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-09T01:06:00.000+02:00", "crawled": "2018-01-09T17:18:50.010+02:00", "highlightTitle": ""}